









Markets
/
Stocks
/
nasdaq-idxx
/

IDEXX Laboratories Inc

IDXX

628.540USD

+0.880+0.14%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

50.38BMarket Cap

51.11P/E TTM



IDEXX Laboratories Inc

628.540

+0.880+0.14%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of IDEXX Laboratories Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IDEXX Laboratories Inc's Score

Industry at a Glance

Industry Ranking

65 / 210

Overall Ranking

147 / 4621

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 16 analysts

Buy

Current Rating

683.863

Target Price

+8.95%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

IDEXX Laboratories Inc Highlights

StrengthsRisks

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 15.74% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 3.90B.

Fairly Valued

The company’s latest PE is 51.92, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 77.56M shares, decreasing 4.63% quarter-over-quarter.

Held by Ron Baron

Star Investor Ron Baron holds 2.03M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.21.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 8.41, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 1.11B, representing a year-over-year increase of 10.55%, while its net profit experienced a year-over-year increase of 44.61%.

Score

Industry at a Glance

Previous score

8.41

Change



Financials

6.45

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.73

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.86

Key Metrics

Free cash flow

No Data

IDEXX Laboratories Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 4.64, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 51.92, which is 22.05% below the recent high of 63.37 and 36.29% above the recent low of 33.08.

Score

Industry at a Glance

Previous score

4.64

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 65/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 7.63, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for IDEXX Laboratories Inc is 720.00, with a high of 785.00 and a low of 425.22.

Score

Industry at a Glance

Previous score

7.63

Change

Support & Resistance

No Data

Analyst Rating

Based on 16 analysts

Buy

Current Rating

683.863

Target Price

+8.95%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

IDEXX Laboratories Inc

IDXX

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 6.71, which is higher than the Healthcare Equipment & Supplies industry's average of 6.55. Sideways: Currently, the stock price is trading between the resistance level at 648.36 and the support level at 611.86, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.69

Change

0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.314

Neutral

RSI(14)

46.217

Neutral

STOCH(KDJ)(9,3,3)

28.769

Sell

ATR(14)

13.034

Low Volatility

CCI(14)

-118.743

Sell

Williams %R

77.385

Sell

TRIX(12,20)

0.014

Sell

StochRSI(14)

4.730

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

635.762

Sell

MA10

636.713

Sell

MA20

633.746

Sell

MA50

637.934

Sell

MA100

601.491

Buy

MA200

525.518

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 96.93%, representing a quarter-over-quarter decrease of 2.80%. The largest institutional shareholder is The Vanguard, holding a total of 9.84M shares, representing 12.30% of shares outstanding, with 4.10% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.84M

+0.20%

BlackRock Institutional Trust Company, N.A.

5.30M

-2.44%

State Street Investment Management (US)

3.55M

-2.62%

Fundsmith LLP

2.64M

-0.34%

Geode Capital Management, L.L.C.

2.46M

+2.26%

Baron Capital Management, Inc.

Star Investors

2.03M

-1.32%

Invesco Capital Management (QQQ Trust)

1.65M

-0.35%

Polen Capital Management, LLC

1.20M

+1519.07%

Principal Global Investors (Equity)

1.13M

+0.16%

William Blair & Company, L.L.C. (Research)

1.08M

-0.94%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 5.84, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.62. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.